ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,805
0,21%
Bitcoin
59 326,05
0,35%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Immunovia Ab (publ) (0G8X)

  7. Immunovia Ab (publ) (0G8X) Actualités

0G8X Immunovia Ab (publ)

191,40
0,00 (0,00%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Immunovia Ab (publ) 0G8X London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 191,40 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
191,40 191,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/1/202416:59PRNUSImmunovia announces financial calendar for financial year..
04/1/202416:58PRNUSImmunovia announces financial calendar for financial year..
21/11/202311:40PRNUSBulletin from the extraordinary general meeting in Immunovia..
21/11/202311:38PRNUSBulletin from the extraordinary general meeting in Immunovia..
09/11/202309:03PRNUSImmunovia Publishes Interim Report for January-September..
09/11/202308:59PRNUSImmunovia Publishes Interim Report for January-September..
07/11/202316:14PRNUSImmunovia successfully completes discovery phase of..
07/11/202316:12PRNUSImmunovia successfully completes discovery phase of..
02/11/202311:02PRNUSInvitation to Immunovia's Q3 presentation
02/11/202311:00PRNUSInvitation to Immunovia's Q3 presentation
27/10/202309:06PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
27/10/202309:03PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
03/10/202311:01PRNUSNomination Committee appointed for Immunovia AB (Publ)
03/10/202310:56PRNUSNomination Committee appointed for Immunovia AB (Publ)
30/8/202312:30PRNUSImmunovia Publishes Interim Report for January-June 2023
30/8/202308:56PRNUSImmunovia Publishes Interim Report for January-June 2023
23/8/202320:08PRNUSInvitation to Immunovia's Q2 presentation
23/8/202320:06PRNUSInvitation to Immunovia's Q2 presentation
19/7/202318:47PRNUSImmunovia announces updated financial calendar
12/7/202309:15PRNUSImmunovia to Significantly Restructure to Focus Resources on..
12/7/202309:12PRNUSImmunovia to Significantly Restructure to Focus Resources on..
09/6/202310:19PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
09/6/202310:11PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
31/5/202312:16PRNUSChange in number of shares and votes in Immunovia AB (publ)
31/5/202312:13PRNUSChange in number of shares and votes in Immunovia AB (publ)
26/5/202313:43PRNUSBulletin from the Annual General Meeting in Immunovia AB
26/5/202313:41PRNUSBulletin from the Annual General Meeting in Immunovia AB
23/5/202309:03PRNUSImmunovia Publishes Interim Report for January-March 2023
23/5/202309:00PRNUSImmunovia Publishes Interim Report for January-March 2023
22/5/202318:55PRNUSChanges to the Nomination Committee's proposal to the Annual..
22/5/202318:51PRNUSChanges to the Nomination Committee's proposal to the Annual..
17/5/202310:43PRNUSInvitation to Immunovia's Q1 presentation
17/5/202310:41PRNUSInvitation to Immunovia's Q1 presentation
06/5/202313:40PRNUSThe board member Philipp von Hugo resigns from Immunovia's..

Dernières Valeurs Consultées

LSE
0G8X
Immunovia Ab (publ)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés